Cargando…

Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that employs its type III secretion system (T3SS) during the acute phase of infection to translocate cytotoxins into the host cell cytoplasm to evade the immune system. The PcrV protein is located at the tip of the T3SS, facilitates the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundin, Charlotta, Saleeb, Michael, Spjut, Sara, Qin, Liena, Elofsson, Mikael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824769/ https://www.ncbi.nlm.nih.gov/pubmed/33406810 http://dx.doi.org/10.3390/biom11010055

Ejemplares similares

Exploring resveratrol dimers as virulence blocking agents – Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa
por: Sundin, Charlotta, et al.
Publicado: (2020)

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon
por: Kundracik, Emma, et al.
Publicado: (2022)

A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
por: Aguilera-Herce, Julia, et al.
Publicado: (2019)

The Resveratrol Tetramer (-)-Hopeaphenol Inhibits Type III Secretion in the Gram-Negative Pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa
por: Zetterström, Caroline E., et al.
Publicado: (2013)

Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa
por: Sato, Hiromi, et al.
Publicado: (2011)

Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions
por: Nanao, Max, et al.
Publicado: (2003)

Type III Secretion Protein, PcrV, Impairs Pseudomonas aeruginosa Biofilm Formation by Increasing M1 Macrophage-Mediated Anti-bacterial Activities
por: Yu, Hua, et al.
Publicado: (2020)

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019)

Development, Optimization, and Validation of a High Throughput Screening Assay for Identification of Tat and Type II Secretion Inhibitors of Pseudomonas aeruginosa
por: Massai, Francesco, et al.
Publicado: (2019)

Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
por: Sato, Hiromi, et al.
Publicado: (2011)

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
por: Asadi Karam, Mohammad Reza, et al.
Publicado: (2022)

Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
por: Jiang, Mingzi, et al.
Publicado: (2014)

Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021)

Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
por: Li, Peng, et al.
Publicado: (2021)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

697. Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Monoclonal Antibody MEDI3902, Are Conserved Among Diverse Hospital Isolates Collected From an International Surveillance Study
por: Tabor, David E
Publicado: (2018)

Synthesis and Application of a 2-[(4-Fluorophenyl)-sulfonyl]ethoxy Carbonyl (Fsec) Protected Glycosyl Donor in Carbohydrate Chemistry
por: Spjut, Sara, et al.
Publicado: (2010)

Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
por: Galle, Marlies, et al.
Publicado: (2012)

Attenuation of Pseudomonas aeruginosa infection by INP0341, a salicylidene acylhydrazide, in a murine model of keratitis
por: Sharma, Prerana, et al.
Publicado: (2020)

Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system
por: Jouault, Albane, et al.
Publicado: (2022)

Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
por: Yu, Hua, et al.
Publicado: (2021)

PcrG protects the two long helical oligomerization domains of PcrV, by an interaction mediated by the intramolecular coiled-coil region of PcrG
por: Basu, Abhishek, et al.
Publicado: (2014)

Intrinsic and Extrinsic Regulation of Type III Secretion Gene Expression in Pseudomonas Aeruginosa
por: Diaz, Manisha R., et al.
Publicado: (2011)

Glutathione Activates Type III Secretion System Through Vfr in Pseudomonas aeruginosa
por: Zhang, Yani, et al.
Publicado: (2019)

The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis
por: Yang, Justin J., et al.
Publicado: (2021)

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia
por: Howell, Heather A., et al.
Publicado: (2013)

Calcium Chelation by Alginate Activates the Type III Secretion System in Mucoid Pseudomonas aeruginosa Biofilms
por: Horsman, Shawn R., et al.
Publicado: (2012)

Diversity of Virulence Phenotypes among Type III Secretion Negative Pseudomonas aeruginosa Clinical Isolates
por: Toska, Jonida, et al.
Publicado: (2014)

Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product
por: Zhu, Miao, et al.
Publicado: (2016)

Cyclopropylmethyl Protection of Phenols: Total Synthesis of the Resveratrol Dimers Anigopreissin A and Resveratrol–Piceatannol Hybrid
por: Kumar, Arvind, et al.
Publicado: (2018)

Property space mapping of Pseudomonas aeruginosa permeability to small molecules
por: Leus, Inga V., et al.
Publicado: (2022)

Novel Type III Effectors in Pseudomonas aeruginosa
por: Burstein, David, et al.
Publicado: (2015)

Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening
por: Tükenmez, Hasan, et al.
Publicado: (2019)

Structural Basis of Cytotoxicity Mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa
por: Gendrin, Claire, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k9vnekihsb9j1gmlnc4l0iqn5p